NCT02618616 - A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis | Biotech Hunter

Enrollment

129

Participants

Timeline

Start Date

January 11, 2016

Primary Completion Date

December 22, 2016

Study Completion Date

December 22, 2016

Conditions

Psoriasis

Interventions

DRUG

ZPL-3893787

DRUG

Placebo

Trial Locations (24)

1000

Belgium Study Centre, Brussels

1090

Belgium Study Centre, Brussels

1200

Belgium Study Centre, Brussels

3000

Belgium Study Centre, Leuven

4000

Belgium Study Centre, Liège

9000

Belgium Study Centre, Ghent

10117

German Study Centre, Berlin

20354

German Study Centre, Hamburg

30625

German Study Centre, Hanover

47574

German Study Centre, Goch

48149

German Study Centre, Münster

55131

German Study Centre, Mainz

15-430

Polish Study Centre, Bialystok

80-405

Polish Study Centre, Gdansk

90-153

Polish Study Centre, Lodz

90-553

Polish Study Centre, Lodz

20-552

Polish Study Centre, Lublin

60-214

Polish Study Centre, Poznan

, 33-100

Polish Study Centre, Tarnów

50-220

Polish Study Centre, Wroclaw

FY2 0JH

UK Study Centre, Blackpool

WS110BN

UK Study Centre, Bridgetown

UK Study Centre, Leeds

M13 9NQ

UK Study Centre, Manchester

All Listed Sponsors

lead

Ziarco Pharma Ltd

INDUSTRY